Prevalence of Metabolic Syndrome in a Rural Community in Nigeria

Metabolic Syndrome and Related Disorders

Volumn 8, Issue 1, 2010, Pages 59-62

  Adegoke, Olajire A ^a   Adedoyin, Rufus A ^a   Balogun, Michael O ^a   Adebayo, Rasaaq A ^a   Bisiriyu, Luqman A ^a   Salawu, Afolabi A ^a  

^a OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NIGERIA; PREVALENCE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL, HDL; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NIGERIA; PREVALENCE; RURAL POPULATION; TRIGLYCERIDES;

EID: 77649107787     PISSN: 15404196     EISSN: None     Source Type: Journal    
DOI: 10.1089/met.2009.0037     Document Type: Article

References (28)

1. Reven GM. Role of insulin in human disease. Diabetes 1989; 37:1595-1607.
2. Eckel RH, Grundy SM, Zimmet P. The metabolic syndrome. Lancet 2005;365:1425-1428
3. Timar O, Sestier F, Levy E: Metabolic syndrome X: A review. Can J Cardiol 2000;16:779-789.
4. World Health Organization. Defi nition, diagnosis and classifi cation of diabetes mellitus and its complications: Report of a WHO consultation. Part I. Diagnosis and classifi cation of diabetes mellitus. Geneva, Switzerland: WHO; 1999.
5. Zimmet P, Alberti G, Shaw J. A new IDF worldwide defi nition of the metabolic syndrome: The rational and the results. Diabetes Voice 2005;50:31-33.
6. Liese AD, Mayer-Davis EJ, Haffner SM et al. Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol Rev 1998;20:157-172.
7. National Cholesterol Education Program. Third Report of the National Cholsterol Education Programme (NCEP) Expert Panel on Detection Evaluation and Treatment of High Blood cholesterol in adults (Adult Treatment Panel III); 2002.
8. Hu G, Giao Q, Tuomilehto J et al. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in non diabetic European man and woman. Arch Intern Med 2004;164:1066-1076.
9. World Health Organization (WHO). Guidelines for conducting community surveys on injury and violence. In: Sethi D, Habibula S, McGee K, Peden M, Bernet S, Hyder AA, Klevens J, Odero W, and Suriyawongpaisal P. (eds). Geneva: World Health Organization; 2004.
10. Adedoyin RA, Mbada CE, Balogun MO, Martins T, Adebayo RA, Akintomide A, Akinwusi P. Prevalence and pattern of hypertension in a semi-urban community in Nigeria. Eur J Cardiovasc Prev Rehabil 2008:15; 683-687.
11. Goldberg EM . Serum cholesterol assay using a stable Liebermann-Burchard reagent. Clin Chem 1969;15:1171-1179.
12. Bachonik PS, Albers JJ. Precipitation methods for quantifi cation of lipoprotein. Methods Enzymol 1986;129:78-100.
13. Buccolo G, David H. Quantitative determination of serum triglycerides by use of enzymes. Clin Chem 1973;19:476-482.
14. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among U. S. adults: Findings from the Third National Health and Nutrition Examination Survey. JAMA 2002;287: 356-359.
15. Leopold F, Beverley B, Andre- Pascal E et al. Metabolic syndrome in a sub-Saharan African setting: Central obesity may be the key determinant. Atherosclerosis 2007;193:70-76.
16. Balkan B, Charles MA, Drivsholm T et al. Frequency of the WHO metabolic syndrome in European cohorts, and an alternative defi nition of an insulin resistance syndrome. Diabetes Metab 2002;28:364-376.
17. Kim WY, Kim JE, Choi YJ et al. Nutritional risk and metabolic syndrome in Korean type 2 diabetes mellitus. Asia Pac J Clin Nutr 2008;17:47-51.
18. Fezeu L. Minkoulou E, Balkkau B et al. Association between socio economic status and adiposity in urban Cameroon. Int J Epidemiol 2006;35:105-111.
19. Sobngwi E, Mbanya JC, Unwin NC et al. Physical activity and its relationship with obesity, hypertension and diabetes in urban and rural Cameroon. Int J Obes Relat Metab Disord 220:26:1009-1016.
20. Franghanel G, Sanchez-Reyes L, Berber A, Gomez-Santos R. Evaluation of the prevalence of obesity in the workers of a general hospital in Mexico. Obes Res 2001;9:268-273.
21. Utuierrez-Fisac JL, Regidor E, Rodriguez C. Economic and social factors associated with body mass index and obesity in the Spanish population aged 20-64 years. Eur J Public Health 1995;5:193-198.
22. Matsuzawa Y, Funahashi T, Kihara S et al. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004;24:29.
23. Meigs JB. Invited commentary: Insulin resistance syndrome, syndrome X, multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol 2000:152:908-911.
24. Isezuo SA. Is high density lipoprotein cholesterol useful in the diagnosis of metabolic syndrome in native Africans with type 2 diabetes? Ethn Dis 2005;15:6-10.
25. Knuiman JT, Hermus RJ, Wautrast JG. Serum total and high density lipoprotein cholesterol concentrations in rural and urban boys from 16 countries. Atherosclerosis 1980;36:529-537.
26. Haffner SM, Valdez RA, Hazude HP, Mitchel BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992;41:715-722.
27. Alwan A, King H. Diabetes in the eastern Mediterranean region: TheWorld Health Organization responds to a major public health challenge. Diabet Med 1995;12:1057-1058.
28. Pan XR, Li GW Hu YH et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: The Da Qing IGT and Diabetes Study. Diabetes Care 1997; 4:537-544.